HTA Review Reference Committee

The HTA Review Reference Committee is responsible for overseeing the Health Technology Assessment (HTA) Policy and Methods Review.

Role

The HTA Review Reference Committee will oversee the Health Technology Assessment (HTA) Policy and Methods Review.

The HTA Review Reference Committee will:

  • agree the terms of reference for the HTA Review
  • agree the expert in HTA to support the HTA Review
  • oversee public consultations and considering submissions to the HTA Review
  • oversee the analysis undertaken by the expert in HTA
  • prepare a final review report and recommendations.

Members

Member Role on the Reference Committee
Adjunct Professor Debora Picone AO Independent Chair
Ms Ann Single Patient Representative
Dr Dawn Casey PSM Patient Representative
Professor Andrew Wilson Chair of the Pharmaceutical Benefits Advisory Committee (PBAC)
Professor Andrew Roberts AM Clinical/Scientific Representative
Ms Elizabeth de Somer Member nominated by Medicines Australia
Ms Adriana Platona PSM Government Nominee

Meetings

The committee holds meetings as needed to meet the 31 December 2023 review deadline.

Health Technology Assessment Policy and Methods Review Reference Committee – Meeting agendas

Health Technology Assessment Policy and Methods Review Reference Committee – Communiques

Probity Plan

Health Technology Assessment Policy and Methods Review Reference Committee Principles – Confidentiality and Transparency 

Health Technology Assessment Policy and Methods Review Reference Committee Principles - Conference Attendance

Contact

HTA Review Secretariat

Contact for the Health Technology Assessment Review
Date last updated: